To date, Argus II artificial retina is implanted in four patients in Iran. The first Argus II retinal prosthesis in Iran was successfully implanted in Shiraz (October 2017). The global experience with Argus II has enrolled no more than 300 cases so far.
![argus developer trail argus developer trail](https://s1.manualzz.com/store/data/006779425_1-9ffed7cba9208e81246a91ce96d96ac2.png)
To obtain better results, expectation counseling and preoperative retinal assessment are critical. Compared to gene therapy Argus II is less costly with a demonstrated favorable outcome, though the vision is yet artificial. Over the past few years, visual prostheses (namely, Argus II retinal implant) and gene therapy have obtained FDA approval in treating blindness resulting from retinitis pigmentosa. 6DANA Brain Health Institute, Iranian Neuroscience Society, Fars Chapter, Shiraz, Iran.
![argus developer trail argus developer trail](https://live.staticflickr.com/8094/8523808362_2c958ef5b6.jpg)
![argus developer trail argus developer trail](https://bloximages.newyork1.vip.townnews.com/jacksonprogress-argus.com/content/tncms/assets/v3/editorial/1/5d/15d075f3-b075-5eea-b65c-d07c3e344bcc/5ad133073cf10.image.jpg)
Mohsen Farvardin 1,2, Mehrdad Afarid 1 †, Adel Attarzadeh 2 †, Mohammad K.